James I. Geller

6.9k citations

163 papers · 4.0k indexed · h-index 35

Impact in

Pulmonary and Respiratory Medicine top 1%
- Renal cell carcinoma treatment
- Sarcoma Diagnosis and Treatment
Pediatrics, Perinatology and Child Health top 1%
- Childhood Cancer Survivors' Quality of Life
- Ethics and Legal Issues in Pediatric Healthcare
- Pediatric Urology and Nephrology Studies

Papers in

Hepatology 18
- Hepatocellular Carcinoma Treatment and Prognosis 17
Pulmonary and Respiratory Medicine 64
- Renal cell carcinoma treatment 50

Co-authors: Jeffrey S. Dome Elizabeth A. Mullen Conrad V. Fernandez Elizabeth J. Perlman Geetika Khanna Peter F. Ehrlich Eric J. Gratias Alexander J. Towbin
Journals: Journal of Clinical Oncology (31 papers)Pediatric Blood & Cancer (28 papers)Cancer (15 papers)Journal of Pediatric Hematology/Oncology (8 papers)Cancers (6 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

James I. Geller

153 papers receiving 4.0k citations

Peers

Countries citing papers authored by James I. Geller

Since Specialization

Citations

This map shows the geographic impact of James I. Geller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James I. Geller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James I. Geller more than expected).

Fields of papers citing papers by James I. Geller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James I. Geller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James I. Geller. The network helps show where James I. Geller may publish in the future.

Co-authors

The 25 scholars most cited alongside James I. Geller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James I. Geller Line = papers co-authored together James I. Geller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways Cancers ·Tiziana Esposito, M. Stepnik, Katherine M. Jennings, Alexander Miethke, Alexander Bondoc, Gregory M. Tiao, James I. Geller, Rebekah Karns, Lubov Timchenko, Nikolai A. Timchenko	2024	1
2	Long‐term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study International Journal of Cancer ·Andrew J. Murphy, Jack Brzezinski, Lindsay A. Renfro, Brett Tornwall, Marcus M. Malek, Daniel J. Benedetti, Nicholas G. Cost, Ethan A. Smith, Jennifer H. Aldrink, Rodrigo Romao, Jeffrey S. Dome, Andrew M. Davidoff, V Hoenig, Joana Dark Dias Moraes, Elizabeth A. Mullen, Robert C. Shamberger, Arnold C. Paulino, Andrea Lo, James I. Geller, Peter F. Ehrlich	2024	3
3	Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients – A narrative literature review to explore the potential benefit for children with cancer SHILAP Revista de lepidopterología ·宮坂美和子, S. Knutzen, James I. Geller, Martine van Grotel, Marc Ansari, Éric Bouffet, Archie Bleyer, Rogério Tadeu de Souza, Michael Sullivan, Alwin D. R. Huitema, R. Katayama, Per Kogner, Rudolf Maibach, Allison F. O’Neill, Vassilios Papadakis, Kaukab Rajput, Gareth J. Veal, Penelope Brock, Zhifei Chen, Marry M. van den Heuvel‐Eibrink	2024	0
4	Outcome after treatment with axitinib in children, young adults, and adults with renal cell carcinoma: a narrative review Critical Reviews in Oncology/Hematology ·R Donald Hardy, Earlene Viano, Filippo Spreafico, Barbara Selle, Tanzina Chowdhury, Norbert Graf, Arnauld Verschuur, D. Gonzalez-Duque, Axel Bex, James I. Geller, Godelieve A.M. Tytgat, Marry M. van den Heuvel‐Eibrink	2024	0
5	Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2 Cancer ·Daniel J. Benedetti, Lindsay A. Renfro, C.A. Mandel, Najat C. Daw, John A. Kalapurakal, Peter F. Ehrlich, Geetika Khanna, Elizabeth J. Perlman, Anne B. Warwick, Kenneth W. Gow, Arnold C. Paulino, Nita L. Seibel, Paul E. Grundy, Conrad V. Fernandez, James I. Geller, Elizabeth A. Mullen, Jeffrey S. Dome	2024	2
6	EZH2 is a key component of hepatoblastoma tumor cell growth Pediatric Blood & Cancer ·Kathryn Glaser, B Archangelskaja, Ana Carolina Oliveira Mesquita, Ricardo Augusto Brandão, Nikolai A. Timchenko, Rebekah Karns, Stefano Cairo, James I. Geller, Gregory M. Tiao, Alexander Bondoc	2023	4
7	Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532 Cancer ·Nicholas F. Evageliou, Lindsay A. Renfro, James I. Geller, Elizabeth J. Perlman, John A. Kalapurakal, Arnold C. Paulino, David Dix, Meryle J. Eklund, Andrew J. Murphy, Rodrigo Romao, Peter F. Ehrlich, Carly R. Varela, Kelly Vallance, Conrad V. Fernandez, Jeffrey S. Dome, Elizabeth A. Mullen	2023	3
8	Children's Oncology Group's 2023 blueprint for research: Renal tumors Pediatric Blood & Cancer ·James I. Geller, Andrew L. Hong, Kelly Vallance, A. H. Guraliuk, Jennifer H. Aldrink, Nicholas G. Cost, V Hoenig, Lindsay A. Renfro, Elizabeth A. Mullen	2023	11
9	Ocular survival after intra‐arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution Pediatric Blood & Cancer ·Nianfeng Liu, Basil K. Williams, Sudhakar Vadivelu, Zélia M. Corrêa, Todd Abruzzo, Maura Di Nicola, Adam Lane, James I. Geller	2022	7
10	Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature Cancers ·Ricardo Hendges, Filippo Spreafico, Ronald R. de Krijger, Jarno Drost, Jesper Brok, Daniela Perotti, Harm van Tinteren, Rajkumar Venkatramani, Jan Godziński, Christian Rübe, James I. Geller, Norbert Graf, Marry M. van den Heuvel‐Eibrink, Annelies M. C. Mavinkurve‐Groothuis	2021	34
11	ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma—A Children's Oncology Group study Cancer ·James I. Geller, Joseph G. Pressey, Malcolm A. Smith, Rachel A. Kudgus, Mariana M. Cajaiba, Joel M. Reid, David Hall, Donald A. Barkauskas, R. Kh. Kazhaeva, Steve Y. Cho, Stacey L. Berg, Jeffrey S. Dome, Elizabeth Fox, Brenda J. Weigel	2020	30
12	Clinical heterogeneity of pediatric hepatocellular carcinoma Pediatric Blood & Cancer ·Gema de la Poza Gómez, Alexander J. Towbin, Anita Gupta, M. Henar Alonso, Jaimie D. Nathan, 남시복, Greg Tiao, James I. Geller	2020	18
13	Surgical management of children and adolescents with upfront completely resected hepatocellular carcinoma Pediatric Blood & Cancer ·Gema de la Poza Gómez, Rachana Shah, Anita Gupta, Alexander J. Towbin, Marı́a Pilar Alonso, Jaimie D. Nathan, 남시복, Greg Tiao, James I. Geller	2018	20
14	Acquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma Pediatric Blood & Cancer ·M. Schiff, Nancy D. Leslie, Anita Gupta, James I. Geller	2018	8
15	A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors Clinical Cancer Research ·Birgit Geoerger, Franck Bourdeaut, Steven G. DuBois, Matthias Fischer, James I. Geller, Nicholas G. Gottardo, Aurélien Marabelle, Andrew D.J. Pearson, Shakeel Modak, Thomas F. Cash, Giles Robinson, Huijun Gao, Alessandro Matano, Suraj G. Bhansali, Jason R. Dobson, Sudha Parasuraman, Susan Chi	2017	121
16	Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients Clinical Cancer Research ·Keri A. Streby, James I. Geller, Mark A. Currier, Patrick Warren, John M. Racadio, Alexander J. Towbin, Valerie Were, Shiv K. Sahu, IC Roberts‐Thomson, José Luis Jiménez Jaramillo, Lori R. Backus, Victor Andrey Barcala Peixoto, J. M. Tangirov, Kathleen Simpson, F.J. González Razo, Joe Conner, Timothy P. Cripe	2017	109
17	Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group Study AREN0532 Journal of Clinical Oncology ·Conrad V. Fernandez, Elizabeth A. Mullen, Yueh‐Yun Chi, Peter F. Ehrlich, Elizabeth J. Perlman, John A. Kalapurakal, Geetika Khanna, Arnold C. Paulino, Thomas E. Hamilton, Kenneth W. Gow, Zelig Tochner, Fredric A. Hoffer, Janice S. Withycombe, Robert C. Shamberger, Yeonil Kim, James I. Geller, James R. Anderson, Paul E. Grundy, Jeffrey S. Dome	2017	59
18	Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group Journal of Clinical Oncology ·Eric J. Gratias, Jeffrey S. Dome, Lawrence J. Jennings, Yueh-Yun Chi, Jing Tian, James C. Anderson, Paul E. Grundy, Elizabeth A. Mullen, James I. Geller, Conrad V. Fernandez, Elizabeth J. Perlman	2016	88
19	Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration Journal of Clinical Oncology ·Jeffrey S. Dome, Norbert Graf, James I. Geller, Conrad V. Fernandez, Elizabeth A. Mullen, Filippo Spreafico, Marry van den Heuvel‐Eibrink, Kathy Pritchard‐Jones	2015	235
20	Adjunctive techniques for optimization of ocular hemodynamics in children undergoing ophthalmic artery infusion chemotherapy Journal of NeuroInterventional Surgery ·Todd Abruzzo, James I. Geller, Herbert B. Nichols, E. Hirota, Zélia M. Corrêa, J.I. Kim, James J. Augsburger	2014	20

About James I. Geller

James I. Geller is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health, Molecular Biology and Oncology, having authored 163 papers that have together received 4.0k indexed citations. Recurring topics across this work include Renal and related cancers (76 papers), Renal cell carcinoma treatment (50 papers), Ethics and Legal Issues in Pediatric Healthcare (19 papers), Pancreatic and Hepatic Oncology Research (18 papers), Neuroblastoma Research and Treatments (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Childhood Cancer Survivors' Quality of Life (14 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.8k citations), Pediatrics, Perinatology and Child Health (761 citations), Molecular Biology (2.5k citations), Hepatology (270 citations) and Urology (186 citations). James I. Geller has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Jeffrey S. Dome, Elizabeth A. Mullen, Conrad V. Fernandez, Elizabeth J. Perlman, Geetika Khanna, Peter F. Ehrlich, Eric J. Gratias, Alexander J. Towbin, Filippo Spreafico and Kathy Pritchard‐Jones. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Cancer, Journal of Pediatric Hematology/Oncology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact